Synapse - Pamela Drullinsky

Results (91)

Adjuvant enzalutamide for the treatment of early-stage androgen-receptor positive, triple-negative breast cancer: A feasibility study

Journal Article

Walsh, E. M.; Gucalp, A.; Patil, S.; Edelweiss, M.; Ross, D. S.; Razavi, P.; Modi, S.; Iyengar, N. M.; Sanford, R.; Troso-Sandoval, T.; more...
Breast Cancer Research and Treatment (2022)

Fulltext@MSK | Save

Prephase rituximab/prednisone therapy and aging-related, proinflammatory cytokine milieu in older, vulnerable patients with newly diagnosed diffuse large B-cell lymphoma

Journal Article

Lin, R. J.; Owens, C. N.; Drill, E.; Iannotta, A.; Oliveros, M.; Schick, D. L.; Noy, A.; Gerecitano, J. F.; Drullinsky, P. R.; Caron, P. C.; more...
Haematologica (2022)

Fulltext@MSK | Save

Morphologic and genomic characteristics of breast cancers occurring in individuals with Lynch syndrome

Journal Article

Schwartz, C. J.; da Silva, E. M.; Marra, A.; Gazzo, A. M.; Selenica, P.; Rai, V. K.; Mandelker, D.; Pareja, F.; Misyura, M.; D'Alfonso, T. M.; more...
Clinical Cancer Research (2022)

Fulltext@MSK | Save

Phase I/Ib study of the efficacy and safety of buparlisib and ibrutinib therapy in MCL, FL, and DLBCL with serial cell-free DNA monitoring

Journal Article

Stewart, C. M.; Michaud, L.; Whiting, K.; Nakajima, R.; Nichols, C.; De Frank, S.; Hamlin, P. A. Jr; Matasar, M. J.; Gerecitano, J. F.; Drullinsky, P.; more...
Clinical Cancer Research (2022)

Fulltext@MSK | Save

Impact of duration of prior cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) therapy on alpelisib (ALP) benefit in patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor-2-negative (HER2-), PIK3CA-mutated advanced breast cancer (ABC) from BYLieve

Meeting Abstract

Chia, S. K. L.; Ruiz-Borrego, M.; Drullinsky, P.; Juric, D.; Bachelot, T.; Rugo, H. S.; Ciruelos, E. M.; Lerebours, F.; Prat, A.; Akdere, M.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Update of a phase II, multicenter study of high-dose chemotherapy with autologous stem cell transplant followed by maintenance romidepsin for T-cell lymphoma

Meeting Abstract

Khan, N.; Khimani, F.; Shustov, A. R.; Shadman, M.; Ruan, J.; Moskowitz, A. J.; Straus, D. J.; Kumar, A.; Sauter, C. S.; Zelenetz, A. D.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Consolidative use of radiotherapy to block (CURB) oligoprogression: Interim analysis of the first randomized study of stereotactic body radiotherapy in patients with oligoprogressive metastatic cancers of the lung and breast

Meeting Abstract

Tsai, C. J.; Yang, J. T.; Guttmann, D. M.; Shaverdian, N.; Shepherd, A. F.; Eng, J.; Gelblum, D.; Xu, A. J.; Namakydoust, A.; Iqbal, A.; more...
International Journal of Radiation Oncology, Biology, Physics (2021)

Fulltext@MSK | Save

The alpelisib (ALP) experience in the SOLAR-1 and BYLieve studies: Perspectives for practitioners caring for patients (pts) with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC)